Skip to main
CNO
CNO logo

CNO Stock Forecast & Price Target

CNO Analyst Ratings

Based on 16 analyst ratings
Buy
Strong Buy 19%
Buy 25%
Hold 50%
Sell 6%
Strong Sell 0%

Bulls say

CNO Financial Group Inc. demonstrated positive performance in its life policy income, which rose by 3.2% year-over-year to $226.5 million, aligning closely with estimates and contributing to an overall policy income growth of 2.7% to $409.4 million. The company also reported a 3.8% sequential increase in book value per share, reaching $37.19, alongside a significant upturn in net investment income, which grew to $147.8 million from the previous year. Additionally, an 8.3% year-over-year increase in agent count and a robust 11.2% rise in consumer new annualized premiums highlight CNO's effective strategy in expanding its market presence and revenue streams.

Bears say

CNO Financial Group's outlook is characterized by declining financial metrics, with the RBC ratio decreasing to 383% from 388%, which signals potential vulnerability in the company's capital position. The company is experiencing a persistent decrease in fee income for the second consecutive year, attributed to a shift towards smaller Medicare Advantage providers, which negatively impacts revenue and growth potential. Additionally, downward trends in annuity profitability and supplemental health margins further contribute to the negative sentiment surrounding CNO's ability to deliver consistent returns and maintain adequate liquidity for upcoming operational needs.

CNO has been analyzed by 16 analysts, with a consensus rating of Buy. 19% of analysts recommend a Strong Buy, 25% recommend Buy, 50% suggest Holding, 6% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of CNO Financial Group and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About CNO Financial Group (CNO) Forecast

Analysts have given CNO a Buy based on their latest research and market trends.

According to 16 analysts, CNO has a Buy consensus rating as of Jun 16, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $25.84, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $25.84, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

CNO Financial Group (CNO)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.